About
SyntheticDesignLab develops next-generation antibody-drug conjugates (ADCs) using a synthetic biologic platform designed to improve cancer treatment by enabling targeted, multifunctional, and multispecific therapies.
Explore SyntheticDesignLab's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.